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Intracellular hemin is a potent
inhibitor of the voltage‑gated
potassium channel Kv10.1
Nirakar Sahoo1,2, Kefan Yang1, Ina Coburger1, Alisa Bernert1, Sandip M. Swain1,6,
Guido Gessner1, Reinhard Kappl3, Toni Kühl4, Diana Imhof4, Toshinori Hoshi5,
Roland Schönherr1 & Stefan H. Heinemann1*
Heme, an iron-protoporphyrin IX complex, is a cofactor bound to various hemoproteins and supports
a broad range of functions, such as electron transfer, oxygen transport, signal transduction, and
drug metabolism. In recent years, there has been a growing recognition of heme as a non-genomic
modulator of ion channel functions. Here, we show that intracellular free heme and hemin modulate
human ether à go-go (hEAG1, Kv10.1) voltage-gated potassium channels. Application of hemin to
the intracellular side potently inhibits Kv10.1 channels with an IC50 of about 4 nM under ambient
and 63 nM under reducing conditions in a weakly voltage-dependent manner, favoring inhibition at
resting potential. Functional studies on channel mutants and biochemical analysis of synthetic and
recombinant channel fragments identified a heme-binding motif CxHx8H in the C-linker region of the
Kv10.1 C terminus, with cysteine 541 and histidines 543 and 552 being important for hemin binding.
Binding of hemin to the C linker may induce a conformational constraint that interferes with channel
gating. Our results demonstrate that heme and hemin are endogenous modulators of Kv10.1 channels
and could be exploited to modulate Kv10.1-mediated cellular functions.
Abbreviations
CNBD	Cyclic nucleotide binding domain
CNS	Central nervous system
DTT	Dithiothreitol
EAG	
Ether à go-go
GSH	Reduced glutathione
Kv channel	Voltage-gated potassium channel
HRM	Heme-regulatory motif
MBP	Maltose-binding protein
MST	Microscale thermophoresis
PAS	Per-ARNT-Sim
PpIX	Protoporphyrin IX
wt	Wild type
The human ether à go-go channel 1 (hEAG1, Kv10.1) is a voltage-gated delayed rectifier potassium ( K+) channel
encoded by the KCNH1 gene. It is the founding member of the EAG family, which also includes Elk and Erg
channels. While the human Erg1 (hERG1, Kv11.1) is critically involved in cardiac excitability, Kv10.1 is primarily
found in the vertebrate nervous system, including the neocortex, olfactory bulb, hippocampus, retinal ganglion,
photoreceptors, cochlear spiral ligament, and skeletal muscle1–4. The physiological importance of Kv10.1 channels in the nervous system is readily evidenced by the hereditary mutations that cause human diseases such as
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Zimmermann-Laband and Temple-Baraitser syndrome. The respective patients suffer from severe neurological
disorders ranging from epilepsy, marked hypotonia in infancy, focal tonic–clonic seizures, severe intellectual
disability, hypoplasia/aplasia of the nails of the thumb and great toe, and pseudo-myopathic a ppearance5–14.
Apart from their physiological functions, Kv10.1 channels are markedly up-regulated in many cancer cells
such as melanomas, breast carcinomas, soft-tissue sarcoma, cervical carcinoma, neuroblastomas, gliomas, gastric
and colorectal cancer, esophageal squamous cell carcinomas, and hepatocellular carcinoma15–23. The aforementioned finding is consistent with the notion that Kv10.1 channels facilitate cell proliferation and, thus, Kv10.1
inhibitors may be therapeutically beneficial. An intensive effort focusing on Kv10.1 has been underway to develop
novel therapeutics24,25.
Despite the progress in characterizing the neurological and cancer phenotypes associated with dysregulation
of Kv10.1 channels, our knowledge of the channel regulation mediated by endogenous modulators remains scarce.
Kv10.1 channels are strongly inhibited by Ca2+/calmodulin26, reactive oxygen species27, and the phospholipid
PIP228,29, and there exists the possibility that more potent endogenous modulators remain to be discovered. Here,
we identify heme and hemin as potent and high-affinity endogenous modulators of Kv10.1 channels.
Heme [Fe(II) protoporphyrin-IX] is a ubiquitous cofactor essential for numerous hemoproteins, such as
hemoglobin, myoglobin, respiratory cytochromes, cytochrome P450 enzymes, oxidases, and catalases. Biological
systems rely on hemoproteins to serve a number of important functions, for example, oxygen transport, respiration, drug detoxification, oxidative metabolism, thyroid hormone synthesis, and signal transduction30,31. Recent
years have witnessed growing recognition of heme and its oxidized form hemin (with F
 e3+ as central ion) as a
non-genomic modulator of ion channel function. For instance, intracellular free heme acutely modulates the
function of large-conductance voltage- and Ca2+-activated K+ channels (Slo1 BKCa)32, epithelial Na+ channels33,
ATP-sensitive K+ channels ( KATP)34, and rapid inactivation of Kv channels mediated by their N-terminal domains
(KV1.4 K+ channels35) or by Kvβ subunits36. A recent report also shows that the Per-ARNT-Sim (PAS) domain
of hERG3 (Kv11.3) channels harbors a binding site for heme37, suggesting that the channels of the EAG family,
comprising Kv10–Kv12, which all have a PAS domain in the N termini of their pore-forming α subunits, might
be subject to regulation by hemin.
Here, we show that Kv10.1 channels are inhibited by low nanomolar concentrations of intracellular heme
and hemin and, thus, are more sensitive than the channels previously shown to be modulated by heme and/or
hemin (see above). By using electrophysiological and biochemical techniques, we reveal that the impact of heme
on the channel does not depend on the PAS domain but that heme directly binds to the intracellular C-linker
region of the channel, where it most likely induces a conformational change to interfere with channel opening.

Results

Hemin potently inhibits Kv10.1 currents. To assess the sensitivity of Kv10.1 channels to intracellular

hemin or heme, we expressed the channel-coding mRNA in Xenopus oocytes and recorded voltage-dependent
currents in membrane patches large enough to give rise to macroscopic currents using the inside-out mode of
the patch-clamp method. As shown in Fig. 1A, increasing concentrations of hemin (1, 10, and 100 nM) progressively diminished the current amplitudes at the test voltages applied (− 40, 40, and 100 mV) with 10 nM inhibiting the current by more than 50%. After hemin application, the current decrease followed an exponential time
course, reaching an almost complete loss of current within about 1 min at 100 nM (Fig. 1B). The inhibitory effect
of hemin was only very slowly reversible by wash and was accelerated by application of the reducing reagent
DTT (Fig. 1C). Less than total recovery may at least in part be associated to functional decline of Kv10.1 channels in the excised patch configuration. The overall inhibitory potency was dependent on [hemin]i with a halfmaximal inhibitory concentration of 1.7 ± 0.3 nM at − 40 mV and 4.2 ± 0.3 nM at 40 mV and a Hill coefficient
of about 1 (Fig. 1D). At 40 mV, we also measured the impact of hemin on Kv10.1 channels in the presence of
reduced glutathione (GSH) to mimic the intracellular redox environment. The IC50 increased from about 4 nM
to 63 nM with 1 mM GSH present (Fig. 1D). Thus, the hemin effect on Kv10.1 channels is redox dependent,
potentially implicating cysteine residues.

Effects of heme and heme‑related chemicals on Kv10.1 channels. To test for the specificity of the

inhibitory action of hemin, we also measured the impact of its components, F
 e2+ (from FeSO4) and protoporphyrin IX (PpIX), on Kv10.1 channels. Kv10.1 current was unaffected 200 s after application of F
 eSO4 (1 µM) or
PpIX (50 nM). Application of MP-11, a small peptide of microperoxidase to which heme is covalently bound,
did not affect Kv10.1 channel current either (Fig. 1E), suggesting that only the free form of heme inhibits Kv10.1
channels. The reduction of the ferriheme iron to the ferrous form (Fe2+) by sodium dithionite (1 mM) did not
alter the current inhibition efficacy, indicating that the electronic state of the iron center is not crucial. Zinc protoporphyrin IX partially inhibited the Kv10.1 current (Fig. 1E). For current traces, see Supplementary Fig. S1.
These results show that only metal-ligated protoporphyrin IX in a free form diminishes the activity of Kv10.1
channels with free heme and hemin being particularly potent inhibitors.

Hemin diminishes K+ currents through Kv10.1 channels in a voltage‑dependent manner.

The
inhibitory effect of hemin could be interpreted as hemin being a pore blocker of the Kv10.1 channel. To gain
insight into the potential mechanism of channel modulation, we measured the voltage-dependent channel activation at 10 nM hemin, i.e., a concentration diminishing the current amplitude by more than 50% but still
leaving enough current for functional analysis. Hemin slows the activation kinetics at positive voltages and
accelerates the deactivation kinetics (Fig. 2A, right). Additionally, hemin shifts the half-activation voltage per
subunit (Vm) to the positive direction from − 67.2 ± 3.3 mV to − 52.4 ± 4.4 mV (n = 6) and the slope factor (km)
from 22.3 ± 1.5 mV to 42.7 ± 2.2 mV (n = 6) (Fig. 2B,C,E). From the relative fraction of the hemin effect on test
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Figure 1.  Kv10.1 current inhibition by hemin. (A) Mean traces of Kv10.1 channel currents from Xenopus
oocyte inside-out patches, stimulated with the indicated pulse protocol, before (black) and recorded at the
indicated times (color) after hemin application at 1 nM (left), 10 nM (center), or 100 nM (right). Traces are
normalized to the maximal current at 40 mV obtained under control conditions. Thick traces are means, sem
is indicated in shading, the number of recordings n in parentheses. (B) Time course of normalized maximal
currents at 40 mV with application of hemin at the indicated concentration at time zero. The superimposed
curves are the results of single-exponential fits. (C) As in (B) with 10 nM hemin application, wash with control
solutions (Wash), and final exposure of the inside-out patch to a control solution with 1 mM DTT. The solid
line is a single-exponential data fit to characterize the onset of current inhibition. (D) Steady-state Kv10.1
current inhibition at 40 mV, recorded from inside-out Xenopus oocyte membrane patches, as a function
of hemin concentration in oxidizing (no GSH, red circles) and reducing (with 1 mM reduced GSH, green
squares) conditions. The continuous curves are the result of Hill fits (Eq. 3) yielding the indicated half-maximal
inhibition concentrations. (E) Mean remaining current at 40 mV in Kv10.1-containing inside-out patches
after 200-s application of hemin (Fe3+), heme (Fe2+), protoporphyrin IX (PpIX), and Zn(II) protoporphyrin IX
(Zn-PpIX) (all at 50 nM concentration), as well as FeSO4 (1 µM) and MP-11 (1 µM). Data are mean ± sem, n in
parentheses. For current traces, see Supplementary Fig. S1. Solutions: Standard K-Asp.

currents (Fig. 2B) and tail currents (Fig. 2C), it is evident that the inhibitory effect is stronger at negative voltages,
and the effect becomes weaker at positive voltages (Fig. 2D). The results suggest that hemin modifies the voltage dependence of Kv10.1 channel activation, and the strongest impact of hemin on the channel is expected to
occur at resting voltages. It is also conceivable that the slow current component at high voltages in the presence
of hemin (see Fig. 2A, scaled traces) originates from partial voltage-dependent unbinding of hemin.

Comparison with other delayed rectifier K+ channels. Kv10.1 channels belong to the large Kv fam-

ily of depolarization-activated K+ channels, all of which are formed by four α subunits with similar functional
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Figure 2.  Voltage dependence of hemin-induced Kv10.1 inhibition. (A, left) Superposition of current traces
recorded from inside-out patches according to the indicated pulse protocol in which depolarizations ranged
from − 110 to 120 mV in 10-mV increments and 5-s interval before (black) and after (red) application of 10 nM
hemin. Holding voltage: − 80 mV. (A, right) Current traces from the experiment shown on the left for the
indicated voltages before (black) and after (red) hemin application. The gray traces are scaled hemin traces to
match the maximal control current. Scale factors applied: 100 mV: 3.92; 40 mV: 5.2; − 40 mV: 10.7. (B) Mean
current measured at the end of test depolarizations as a function of voltage with superimposed data fits
according to Eq. (1). (C) Tail currents at − 140 mV as a function of test voltage with superimposed Boltzmann
fits (Eq. 2). The dashed lines indicate the current normalized to the maximal current obtained in the fits (right
axis). (D) Voltage dependence of relative current remaining after application of 10 nM hemin determined from
test currents (B) (circles) and tail currents (C) (squares). (E) Parameters describing the voltage dependence of
channel activation according to Eq. (1) without (−) and with 10 nM hemin (+); data are mean ± sem (n = 6).
Solution: Standard K-Asp.
modules such as voltage sensor and pore domain. To infer a potential specificity of the heme impact on Kv10.1
channel activation, we also assessed the hemin sensitivity of select Kv channel isoforms in inside-out patches
from Xenopus oocytes with application of 200 nM hemin, i.e., a concentration that completely inhibits Kv10.1
channels after about 100 s (Fig. 3A,B). The related Kv11.1 (hERG1) channels with the pore mutation S620T to
remove inactivation (Kv11.1-ni) and, hence, to make them more easily accessible to inside-out recordings from
Xenopus oocyte membranes, were also potently inhibited by hemin, leaving only about 10% of the current after
200 s but showing a slower onset than observed for Kv10.1 channels (Fig. 3A,B). Under identical conditions,
Kv1.1 and Kv1.5 channels were not inhibited by hemin (Fig. 3A–C).
In contrast with the inhibitory effect observed with application of hemin to the intracellular side, extracellular
application of hemin (200 nM and 1 µM) did not decrease whole-cell currents from Kv10.1 and Kv11.1 channels
expressed in HEK293T cells (Supplementary Fig. S2).
The hemin sensitivity of Kv10.1 and Kv11.1 might be similar to that of Kv11.3 (KCNH7, hERG3), another EAG
family member, for which a heme-binding site has been reported in the PAS domain of the cytosolic N termini of
the α subunits37. We therefore generated a mutant of Kv10.1 that completely lacked the N terminus (ΔN, Δ2–190),
thus comprising no PAS domain (Fig. 4A). Current carried by this mutant in inside-out patches—similarly to
the wild type—was completely inhibited by application of 200 nM hemin (Fig. 3D,E), thus rejecting the idea that
heme binding to the PAS domain causes the Kv10.1 channel’s heme sensitivity. It should be noted that variant
ΔN has altered gating properties, requiring strong hyperpolarization to keep the channel closed.

Identification of the molecular loci required for the hemin–Kv10.1 channel interaction. With
the observation of the potent inhibition of the Kv10.1 channels by hemin and the exclusion of the PAS domain
as a possible binding site, we sought to identify the molecular locus of Kv10.1 that mediates this interaction.
Amino-acid sequence inspection reveals that Kv10.1 channels do not contain the heme-binding motif “CxxCH”
as found in cytochrome c and Slo1 B
 KCa channels32. However, there is a potential heme-binding motif C
 xHx8H,
with a cysteine residue (C541) and two histidine residues (H543 and H552), in the C-linker region of the channel protein (Fig. 4A,B), connecting the last transmembrane segment (S6) with the large intracellular cytosolic
domain. Sequence alignment of the C-linker region of the cyclic nucleotide-binding domain (CNBD) family
of channels comprising of EAG family (Kv10.1, Kv11.1, Kv11.3, Kv12.1), plant K
 + channels (AKT1 and KAT1),
and cyclic nucleotide-gated channels (HCN1 and CNGA2) revealed the conservation of this potential hemebinding motif CxHx8H only in the EAG family (modified to CxHx8C in Kv11.3), while absent in plant K+ and
CNG-gated channels (Fig. 4B). Consistent with the absence of this motif in CNGA2, these channels in inside-out
patches from Xenopus oocytes were insensitive to 200 nM hemin applied to the intracellular side (Supplementary Fig. S3).
We tested the Kv10.1 variants C541A, H543A, and H552V for hemin inhibition (the variant H552A did not
result in functional channels). Application of 100 nM hemin under reducing conditions to the intracellular side
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Figure 3.  Effect of intracellular hemin on voltage-gated K+ channels. (A) Averaged current responses,
normalized to the maximal control current at 40 mV (80 mV for Kv11.1-ni), of the indicated channel types
recorded from inside-out patches of Xenopus oocytes before (black) and 180 s after (color) application of
200 nM hemin. Depolarization steps were applied to 0 and 40 mV for Kv10.1, Kv1.1, and Kv1.5 channels, and to
40 and 80 mV for Kv11.1-ni. Thick traces are means; shading indicates sem; for n see panel (C). (B) Normalized,
mean maximal currents at 40 mV (80 mV for Kv11.1-ni) as a function of time after application of 200 nM hemin
at time zero. Straight lines connect data points for clarity. (C) Averaged relative current remaining 180 s after
application of 200 nM hemin for the indicated channel types. Data are mean ± sem, the numbers of independent
experiments are indicated in parentheses. (D) Representative current traces recorded from inside-out Xenopus
oocyte patches with Kv10.1 wild-type channels (left) at 40 mV before (black) and 150 s after application of
200 nM hemin. Right: Current traces for the N-terminal deletion mutant (∆N) before (blue) and 90 s after
application of 200 nM hemin (red). Holding potential for Kv10.1 was − 80 mV and for Kv10.1∆N − 120 mV; the
latter traces are shown without p/n leak subtraction because of high channel activity in the leak voltage range.
(E) Time course of current decrease after application of 200 nM hemin for the indicated channel types: Kv10.1
(n = 8) and Kv10.1∆N (n = 4).
of inside-out patches expressing these singly mutated channels showed diminished but clearly observable inhibition (Fig. 4D). The combination of these mutations together, without noticeable influence on channel gating
(Fig. 4C), largely eliminated the hemin inhibitory effect (Fig. 4C,D); C541, H543, and H552 are therefore critical
residues on Kv10.1 for hemin inhibition.

Hemin binding to peptides and recombinant channel fragments harboring a CxHx8H
motif. The results presented so far suggest that hemin physically binds to the heme-binding motif CxHx8H in

the C-linker region of the Kv10.1 channel. To evaluate the interaction quantitatively, we employed electron paramagnetic resonance (EPR) spectroscopy with 22-mer peptides corresponding to the C-linker segment including
the CxHx8H motif and variants thereof. When incubated with hemin, the wild-type peptide (termed CHH)
showed a rhombic signal typical for low-spin Fe3+ with Landé factor g = 2.23 (Fig. 5), which is almost identical
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Figure 4.  Involvement of the C-linker motif CxHx8H for the impact of hemin on Kv10.1. (A) Two opposing
subunits of rat Kv10.1 (5K7L)53 indicating for one subunit (green) the transmembrane segments with the voltage
sensor, the N-terminal PAS domain (cyan) and the deletion site G190 to yield Δ2-190, as well as the C-terminal
C linker (magenta) which ends in the identified hemin-binding motif encompassing C541..H552 (red). For
clarity, the other two subunits in the view direction as well as the calmodulin molecules present in 5K7L are
not shown. (B) Multiple sequence alignment of the C-linker region of the CNBD family of channels shows that
the heme-binding motif ( CxHx8H) is conserved in some members of the EAG family (Kv10.1, Kv11.1), while
absent in ELK1 (Kv12.1), in the plant K+ channels AKT1 and KAT1, and the cyclic nucleotide-gated channels
HCN1 and CNGA2. The putative heme-binding motif is highlighted. The vertical blue lines mark the peptide
sequence used for the synthesis of 22-mer peptides. (C) Representative inside-out current traces from Xenopus
oocyte membrane patches at 40 mV before (black, blue) and after hemin application (100 nM in 1 mM reduced
GSH, red) for Kv10.1 wild type (wt) and variant C541A:H543A:H552V (CA:HA:HV). (D) Time course of
current reduction upon application of 100 nM hemin in reduced GSH for the indicated channel types. Data are
mean ± sem with n in parentheses (for wt and CA:HA:HV sem in shading). Straight lines connect data points for
clarity.

with our previous report on hemin-Kv1.4 N-terminal peptide interaction35. Importantly, cysteine variant C541A
(termed AHH), the double-histidine variant H543A:H552A (termed CAA), and a combination of the three
mutations C541A:H543A:H552A (termed AAA) abolished the rhombic signal, while the spectra of the single
histidine variants H543A (CAH) and H552A (CHA) had some similarity with that of the wild type. The cysteine
and both histidines in the CxHx8H motif thus appear to be relevant for hemin binding to the Kv10.1 channel.
A compatible ranking of the binding capacity was obtained for the analysis of variants of CxHx8H motif
22-mer peptides incubated with increasing hemin concentrations using UV/Vis spectroscopy in the range of
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Figure 5.  Hemin binding to Kv10.1 C-linker peptides confirmed with EPR spectroscopy. EPR measurements
of 22-mer C-linker peptides encompassing the heme-binding residues C541, H543, and H552 of the indicated
peptides (125 µM) and hemin (100 µM) at 9 K. Arrows mark the g factor 2.23, representing rhombic signals
typical for axial ligation of the low-spin hemin iron. Abbreviations used: (wt) CHH, (C541A:H543A:H552A)
AAA, (C541A) AHH, (H543A) CAH, (H552A) CHA, and (H543A:H552A) CAA. (top, left) Sequences for the
wild-type (CHH) and mutant AAA peptide.

300–600 nm (Supplementary Fig. S4). For the peptides studied, a bathochromic shift of the Soret band to
416–424 nm was observed, and noticeable differences were detected for the corresponding KD values. While the
wild-type 22-mer showed strong binding affinity (1.06 ± 0.93 µM) and a Soret shift to 416 nm, single substitutions of histidine residues in peptides CAH and CHV lowered the binding affinity (CAH: 4.57 ± 0.91 µM, CHV:
5.8 ± 2.7 µM). Interestingly, a shift of the Soret band deviating from the wild-type 22-mer was observed for the
CHV variant (424 nm). Mutation of both histidines (CAV) showed a comparable shift to 423 nm concomitant
with a further decrease in binding affinity (28.0 ± 6.8 µM) approximating a non-binding interaction of heme to
the peptide. Analysis of variant C541A (AHH) also revealed an increased KD value (9.5 ± 2.9 µM) and a Soret
shift to 417 nm, indicating that all three amino acids are involved in binding to hemin.
The synthetic peptide approach may not fully recapitulate the hemin–channel interaction. We thus recombinantly produced and purified the C-linker/CNBHD protein comprised of 196 amino acids from Kv10.1:M478N673 fused to MBP-(His)6 termed as “pep196” carrying the CxHx8H heme-binding motif. When analyzed with
microscale thermophoresis (MST), a method allowing to work with substantially smaller hemin concentrations
than required for UV/Vis spectroscopy, titration of hemin against labelled Kv10.1 pep196 induced a change in
the MST signal (Supplementary Fig. S5), which reflects temperature-dependent sample mobility. Determination of the binding strength revealed tight binding with a binding constant of 150 ± 68 nM. Concentrations
of hemin greater than 625 nM resulted in fluorescence quenching suggesting unspecific binding of hemin or
binding to the His tag. In the low-concentration range a much weaker MST signal was recorded for variant
C541A:H543A:H552V, supporting the heme-binding capacity of the C-linker domain (Supplementary Fig. S5).

Discussion

The results described here, obtained with electrophysiological and various binding assays, together demonstrate
that Kv10.1 channels are directly inhibited by free hemin with an exquisite sensitivity with a half-inhibitory concentration of ~ 4 nM. This high affinity is in contrast with the lower affinities of similar modulation phenomena
previously reported for other ion channel types: Slo1 B
 KCa (IC50 ~ 70 nM32), ENaC (IC50 ~ 24 nM33), and Kv1.4
(EC50 ~ 20 nM35). The high-affinity Kv10.1–hemin interaction suggests that intracellular heme may play yet-to-be
discovered physiological roles in the cells expressing Kv10.1 channels.
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Hampered by various technical constraints, the cytosolic free heme concentrations in mammalian cells are yet
to be determined, with estimates ranging from ~ 5 to ~ 150 nM38–42. In line with these estimates, the KD values of
heme oxygenase 1 (HMOX1) and 2 (HMOX2) are about 1 µM and 0.4 µM, respectively. Thus, Kv10.1 channels
with an IC50 of ~ 4 nM hemin or about 60 nM under reducing conditions possess great potential for interactions
with heme/hemin and suggest that Kv10.1 channels may have heme/hemin bound under physiological conditions although we did not see a clear indication that some of the channels were inhibited by endogenous heme
in Xenopus oocytes before exogenous application. It is also possible that the presence of GSH not only affects
the redox properties but also scavenges free hemin by b
 inding43. With respect to the remarkably low IC50 of
Kv10.1 channels to hemin under ambient conditions (~ 4 nM), it is important to note that the actual redox state
of heme/hemin in the cytosol is not really clear. Given the overall reducing conditions in the mammalian cell,
the predominant presence of heme with ferrous iron ( Fe2+) was commonly assumed. However, recent evidence
based on heme oxygenase-2 (HO-2) activity in HEK293 cells is more consistent with labile (free) heme being
oxidized44. Therefore, even the lowest estimate for free cytosolic heme/hemin concentration (5 nM) implies
that Kv10.1 channels experience heme modulation in mammalian cells. The exact contribution of the hemin
modulation of Kv10.1 channels to cell physiology and pathophysiology remains to be revealed. EAG (Kv10-12)
K+ channels contribute to neuronal and cardiac action potentials, and their failure or gain-of-function has been
associated with severe cardiac and neurological diseases. Kv10.1 channels are implicated in tumor p
 rogression17
and early steps in d
 evelopment7, and therefore the level of available heme in cells may be a relevant factor in
critical transitions of cells during cell-cycle progression or differentiation.
The EAG ion channel family, comprised of EAG (Kv10), ERG (Kv11), and ELK (Kv12), is a member of CNBD
super-family of channels including hyperpolarization-activated channels, cyclic nucleotide-gated channels, and
numerous plant and bacterial c hannels45. These channels share a common transmembrane core structure as
well as the C-terminal CNBD and the C-linker domain that links the CNBD to the transmembrane domain.
Alignment of the C-linker region of the CNBD family of channels revealed a conserved heme-binding motif
(C541, H543, and H552) in Kv11.1 channels, while the plant K+ channels KAT1 and AKT1 carry no cysteine
and only one single histidine (Fig. 4B). CNGA2 and HCN1 channels harbor one cysteine and one histidine in
the C-linker region (Fig. 4B), but our electrophysiological results show that CNGA2 channels are insensitive to
hemin (Supplementary Fig. S3). This observation indicates that the hemin sensitivity is specific to the C-linker
cysteine and histidine residues in Kv10.1 and Kv11.1 channels.
Previous studies have shown that heme can bind to the PAS domains of various p
 roteins46. Since the N terminus of Kv10.1 also harbors a PAS domain, we functionally examined a deletion construct that lacks the PAS
domain. Even after deleting 189 residues in the N terminus (Kv10.1∆N), this channel fully retains its sensitivity
to intracellular hemin (200 nM; Fig. 3D,E). Although the gating properties of Kv10.1∆N are altered with respect
to the wild type, this finding demonstrates that the PAS domain of the Kv10.1 channel is not responsible for the
hemin effect described in this study. This conclusion is in contrast with the suggestion by Burton et al.37 that
the PAS domain mediates the inhibitory effect of heme on Kv11.3 (hERG3). Burton et al.37 observed the hemin
effect on Kv11.3 channels from the intracellular and the extracellular side of the channel. Kv11.3 channels were
about half-inhibited by 500 nM h
 emin37, while we observed that the half-maximal inhibitory concentrations
for Kv10.1 were 4.2 nM under ambient and 63 nM under reducing conditions. Extracellular application of even
1 µM hemin in HEK293T cells neither diminished the current amplitude of Kv10.1 nor of Kv11.1 (Supplementary Fig. S2). Structurally, Kv10.1, Kv11.1, and Kv11.3 share similar C-linker and N-terminal PAS domains but
multiple mechanisms may be operative to account for the above divergent observations. Our mutagenesis using
Kv10.1 strongly suggests that the inhibitory effect of hemin does not require the N-terminal PAS domain.
Kinetic analysis of the inhibitory interaction between the Kv10.1 channel and hemin at various voltages and
hemin concentrations revealed that the "on" kinetics is concentration dependent, becoming faster with increasing
hemin concentrations, whereas the "off " kinetics is very slow and concentration independent. We suggest that a
single hemin molecule bound to a tetrameric channel complex has a functional impact, but we cannot exclude
multiple—in particular low-affinity—binding sites within a subunit. Hemin is a gating modifier rather than a
pore blocker for BKCa channel function, increasing the open probability (Po) at negative voltages and decreasing
it at more positive voltages47. Hemin also dramatically lowers the Po in ENaC channels33. Our results also indicate
that hemin modifies conformational changes involved in Kv10.1 channel gating: hemin shifted the voltage of
half-maximal activation by 15 mV, enhancing the inhibition at resting voltages and diminishing it under strong
depolarization. Additionally, hemin delays the activation kinetics at positive voltages and accelerates the deactivation kinetics at negative voltages. Hemin also decreases the number of Kv10.1 channels available to open on
depolarization so that the peak current size at very positive voltages is smaller (Figs. 1, 2).
Our previous studies on heme modulation of Slo1 BKCa, Kv1.4, and Kv/Kvβ channels32,35,36 suggest that the
hemin effect is dependent on cysteine residues. For Kv10.1 we identified a heme-binding motif containing a
cysteine residue (C541), which may explain that the reducing agent DTT accelerates recovery from the hemin
effect (Fig. 1C) and that GSH increases the apparent inhibitory constant (Fig. 1D). The partial recovery after
hemin washout may furthermore be related to hemin-mediated oxidation of the channel protein at other sites
because Kv10.1 channels are strongly sensitive to select cysteine-specific m
 odifiers27.
In summary, heme and hemin have a potent inhibitory gating impact on Kv10.1 potassium channels, mediated
by the cysteine- and histidine-containing binding motif (CxHx8H) in the C linker connecting the transmembrane
domain and cytoplasmic CNBD. The location of this motif in the C-linker domain is consistent with the previously postulated notion that the C-linker domain is a critical modulator of EAG channel g ating27,48. Given the
well-recognized importance of Kv10.1 channels in a wide variety of pathophysiological conditions, the identification of heme and hemin as very potent natural inhibitors of Kv10.1 channels may serve as an important lead for
the development of drugs targeting symptoms of Kv10.1-based gain-of-function mutations.
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Materials and methods

Channel constructs and mRNA synthesis. We used KCNH1 (hEAG1, Kv10.1, acc. no. AJ0013668),

KCNH2 (hERG1, Kv11.1, acc. no. NM_000238) and its pore mutant S620T, which exhibits strongly impaired
inactivation49 (KCNH2-S620T, here referred to as Kv11.1-ni), Kcna1 (rat Kv1.1, acc. no. P10499), and KCNA5
(human Kv1.5, acc. no. P22460). Kv10.1 channel mutant constructs C541A, H543A, H552V, and Δ2–190 were
prepared by using overlap-extension mutagenesis as described previously26. We also utilized the human cyclicnucleotide gated channel CNGA2 (acc. no. NM_005140.1).
For the Xenopus oocyte expression system, channel constructs were cloned into the pGEM-HE plasmid, which
was then used for synthesis of capped mRNA by using the mMessage mMachine kit (Ambion, Austin, TX, USA).
For expression in human embryonic kidney cells (HEK293T, ATCC: CRL-1573), the channel constructs were
inserted into pcDNA3.1.

Chemicals. Hemin (Fe(III) protoporphyrin IX), protoporphyrin IX, Zn(II) protoporphyrin IX, F eSO4,
microperoxidase (MP-11), and sodium dithionite were purchased from Sigma-Aldrich. For each electrophysiological recording, working solutions were freshly prepared by diluting the stock solution (1 mM in 30 mM
KOH) with the intracellular recording solutions. The solutions were kept at 4 °C and utilized within 20 min.
Oocyte preparation and mRNA injection. Oocytes were surgically extracted from ovarian tissue of
Xenopus laevis that had been anesthetized by immersion in ice water/tricaine. The protocol was approved by the
University Hospital Jena animal welfare committee (registration no. 02-104/13). All methods were carried out
in accordance with relevant guidelines and regulations and reported in accordance with ARRIVE guidelines.
Defolliculated stage V and VI oocytes were microinjected with 50 nl of mRNA coding wild-type or mutant channels and patch-clamp recordings were performed 2–4 days following mRNA injection after removing vitelline
membranes.
Electrophysiological recordings.

Ion currents from Xenopus oocytes were measured by using an EPC-9
patch-clamp amplifier and PatchMaster software (both HEKA Elektronik, Lambrecht, Germany) at room temperature (20–24 °C). Macroscopic currents in the inside-out configuration were measured with aluminum silicate glass pipettes of about 1 MΩ resistance in the recording solutions. Modulator-containing solutions were
applied directly to the pipette containing the membrane patch using a self-made multi-channel perfusion system. Solution exchange was achieved by moving the pipette tip with an inside-out patch from one outlet to the
next, thus ensuring absolutely clean solutions. The intracellular solutions contained (in mM): 100 K-aspartate,
15 KCl, 1 GSH (reduced glutathione), 10 EGTA (ethyleneglycol-bis(β-aminoethyl)-N,N,Nʹ,Nʹ-tetraacetic acid),
and 10 HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (pH 8.0 with KOH). The extracellular
solution contained (in mM): 103.6 Na-aspartate, 11.4 KCl, 1.8 C
 aCl2, and 10 HEPES (pH 7.2 with NaOH). For
recordings with symmetrical K
 + concentration (termed “Standard K-Asp”), K-aspartate replaced Na-aspartate in
the external solution, and the pH was adjusted with KOH. The holding potential was − 100 mV, and depolarizing
pulses were applied with a sweep interval of 2 s for current–voltage relationships and 10 s for assaying the time
course of the hemin impact. Deviations are explicitly indicated.
Ion currents from HEK293T cells were recorded using the whole-cell configuration at room temperature
(20–24 °C). Patch pipettes were fabricated from borosilicate glass (BioMedical Instruments, Zöllnitz, Germany)
and were coated with dental wax (Patterson Dental, Mendota Heights, MN, USA) to decrease their capacitance.
After fire-polishing the pipettes, resistances of 0.9–2.0 MΩ were obtained. An agar bridge connected the bath
solution and the ground electrode. Up to 85% of the series resistance was electronically compensated, and all
voltages were corrected for liquid junction potential. For Kv10.1 channels, the external solution composed of
(in mM) 146 NaCl, 4 KCl, 0.2 C
 aCl2, 0.2 MgCl2, and 10 HEPES (pH 7.4 with NaOH) and the internal solution
contained (in mM) 115 K-Asp, 15 KCl, 2.56 MgCl2, 10 EGTA, and 10 HEPES (pH 7.4 KOH). For Kv11.1 channels, the external solution (in mM): 140 NaCl, 10 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES (pH 7.4 with NaOH) and the
internal solution (in mM): 130 KCl, 2.56 M
 gCl2, 10 EGTA, 10 HEPES (pH 7.4 with KOH) were used. Working
solutions with hemin were applied by adding 1 ml of 3 × concentrated hemin solution to the bath chamber with
2 ml control solution.

Expression and purification of Kv10.1 C‑terminal peptides. The amino-acid sequence M478-N673

of Kv10.1 encompassing the heme-binding site was subcloned into a modified pMALc2T vector carrying maltose-binding protein (MBP) and a (His)6-tag, thus generating an MBP-(His)6-peptide fusion protein. The recombinant protein was expressed in Escherichia coli BL21(DE3) pRIL. Cells were grown in YT medium and were
induced with 0.5 mM IPTG at 22 °C for 20 h. Cells were harvested by centrifugation at 4000g for 20 min at 4 °C.
The protein pellet was solubilized in buffer A (50 mM Tris, 500 mM NaCl, 5 mM DTT, pH 8.0) and lysed by sonification. The cell lysate was then centrifuged and the clear supernatant was used in the final purification system
consisting of HisTrap FF crude column (GE Healthcare), washed with buffer A + 16 mM imidazole, and eluted
with buffer B (buffer A + 250 mM imidazole). The eluted fractions containing the His-tagged Kv10.1 M478-N673
were further purified using a gel filtration column ( Superdex® 200 Increase 10/300 GL) equilibrated with buffer
C (PBS, pH 7.4, 1 mM TCEP).

Microscale thermophoresis (MST). MST experiments were performed with the Monolith NT.115 (NanoTem-

per Technologies, Munich, Germany) in a buffer containing PBS with pH 7.4, 2 mM GSH, and 0.05% Tween-20. Purified Kv10.1 was labeled according to the manufacturer´s instructions using the Labelling Kit Monolith NT RED-NHS
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(NanoTemper Technologies), and the concentration was adjusted to approximately 100 nM. Hemin was titrated in
1:1 dilutions, starting with a concentration of 40 µM. Each sample was centrifuged at 13,000 rpm for 5 min to remove
aggregates before filled into hydrophilic or premium capillaries (NanoTemper Technologies).

Peptide synthesis and purification. Peptides of 22 residues (Supplementary Table 1) were synthesized on
an automated peptide synthesizer EPS 221 (Intavis Bioanalytical Instruments AG, Cologne, Germany) according to a standard Fmoc-protocol as described e arlier50. The 22-mer control peptide “CHH” was synthesized
manually (see below). The polymer support was Tentagel amide resin with a loading capacity of 0.53 mmol/g
(22-mer peptides; IRIS Biotech, Marktredwitz, Germany) or Rink amide MBHA resin with a loading capacity of
0.73 mmol/g (hEAG-1; Novabiochem, Merck Biosciences, Germany).
For manual peptide synthesis, coupling reactions were performed as double couplings using Fmoc-amino
acids (4 equiv.) activated with 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphonate
(HBTU, 4 equiv.), and 1-hydroxy-1H-benzotriazole (HOBt, 4 equiv.) in the presence of DMF and DIEA (8
equiv.). Fmoc removal was carried out by treating the resin twice with 20% piperidine in DMF. All deprotection
and coupling steps were followed by intensive washings using DMF and DCM, alternately. Peptide cleavage
and purification were performed as described e arlier50. Analytical data are provided in Supplementary Table 1.
UV/visible (UV/Vis) spectroscopy.

Hemin (1 mM) was prepared by dissolving it in 30 mM NaOH and
incubated for 30 min. Subsequently, it was diluted to 100 µM in 0.1 M HEPES buffer (pH 7.0) and directly used
for titration of the peptide solution. Peptide solutions (1 mM) were prepared freshly from the lyophilized powder
by addition of 0.1 M HEPES buffer (pH 7.0). Varying concentrations of hemin (0.4–40 µM) were mixed with
the peptide (5–30 µM) and incubated for 30 min before measurement of the absorption spectra (λ = 230 nm
to 750 nm) using a UV/Vis spectrophotometer V650 (Jasco, Gross-Umstadt, Germany), a UV-3100PC (VWR,
Darmstadt, Germany), or a Multiskan Go (Thermo Fisher Scientific Inc., Waltham, MA, USA). Evaluation of the
obtained spectra was performed as described earlier51,52.

Electron paramagnetic resonance (EPR) spectroscopy. EPR analysis of hemin binding to 22-mer
Kv10.1 C-linker peptides was performed as described previously35. Briefly, samples of the Kv10.1 C-linker
22-mer peptides of the wild-type sequence (termed “CHH”, DICVHLNRKVFKEHPAFRLASD) and the respective single, double and triple mutants (Supplementary Table 1) were prepared in 20 mM Tris, pH 7.5, buffer with
40–50% (vol/vol) ethylene glycol at 25 °C. Samples (100 µl) were filled in EPR tubes and frozen in liquid nitrogen. EPR spectra were recorded at 9 K (Oxford ESR900 cryostat) on a Bruker Elexsys spectrometer operating in
continuous wave mode with a modulation amplitude of 0.8 mT at a frequency of 100 kHz. Microwave power was
set to 8 mW. The background signals were eliminated by subtracting control spectra from buffer samples (without protein and hemin) measured under identical conditions. The apparent g factors were determined using the
WINEPR or XeprView programs (Bruker).
Data analysis. Data were analyzed with FitMaster (HEKA Elektronik), FITMASTER NEXT (Multi Channel
Systems MCS GmbH, Reutlingen, Germany), and IgorPro software (WaveMetrics, Lake Oswego, OR). Data are
presented as mean ± sem with the number of independent measurements, n.
The relationship of maximal current at the end of the test pulses as a function of voltage was described assuming four independent subunits as follows:

I(V ) = Ŵ (V − Erev ) 

1
4
1 + e−(V −Vm )/km

.

(1)

With the conductance Γ, the reversal potential Erev (which is close to zero under symmetrical K+ concentration), the half-maximal activation voltage Vm, and the slope factor km characterizing the voltage dependence of
individual subunits. For the tail current (Itail), i.e., the maximal current obtained in a segment following the test
segments, Eq. (1) reduces to:

Imax
Itail (V ) = 
4 .
−(V
1 + e −Vm )/km

(2)

Concentration (c) dependence of current inhibition was described with a Hill equation:

I(c)
1
n ,
 
=
ICtrl
1 + c IC50 H

(3)

with the half-inhibitory concentration IC50 and the Hill coefficient nH.

Data availability

The analyzed data supporting the conclusions of this article are included in the article and the supplementary
material. Further datasets acquired during the current study are available from the corresponding author on
reasonable request.
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